• 페이스북 공유
  • 트위터 공유
  • 미투데이 공유
  • URL복사
  • 더보기
  • 관심의료진 등록

안태훈

  • 진료과

    순환기내과

  • 전문진료분야

    협심증, 심혈관중재시술, 고지혈증, 고혈압, 판막질환시술, 말초혈관질환

  • 담당클리닉

    흉통클리닉

  • 관련센터

    심혈관센터

안태훈

안태훈 교수의 진료시간표 진료예약

진료과/센터 전문진료과목
순환기내과 - - - - - - 협심증 , 심혈관중재시술 , 고지혈증 , 고혈압 , 판막질환시술 , 말초혈관질환
심혈관센터 -
종일
- - - - 협심증 , 심혈관중재시술 , 고지혈증 , 고혈압 , 판막질환시술 , 말초혈관질환

안태훈 교수의 상세정보

학력

more
  •  ~  1982  :  고려대학교 의과대학 졸업(의학사)
  •  ~  1988  :  고려대학교 의학석사
  •  ~  1991  :  고려대학교 의학박사

경력

more
  • 1989  ~  1991  :  고려대학교의료원 혜화병원 순환기내과 임상강사
  • 1991  ~  1997  :  가천의대길병원 심장내과 과장
  • 1997  ~  1999  :  캐나다 몬트리올심장센타 심혈관중재 임상 및 연구 fellow
  • 1999  ~  2002  :  가천의대길병원 심장내과 부교수
  • 2002  ~  2020  :  가천의대길병원 심장내과 교수
  • 2004  ~  2005  :  가천의대길병원 심장내과 분과장
  • 2004  ~  2009  :  가천의대길병원 심장센터 심도자실 실장
  • 2005  ~  2009  :  가천의대길병원 내과 과장 및 주임교수
  • 2009  ~  2013  :  가천의대길병원 심장센터 소장
  • 2016  ~  2019  :  가천의대길병원 심장혈관센터 소장

수상내역

more
  • 2011  :  대한내과학회 학술상
  • 2017  :  대한심장학회 아스트라제네카 의학상

학회활동

more
  • 2008  ~  2012  :  KVIS (혈관중재술연구회) 회장
  • 2008  ~   :  대한심혈관중재학회 평의원
  • 2005  ~   :  대한내과학회 평의원
  • 2006  ~   :  대한심장학회 평의원
  • 2012  ~  2014  :  대한심장학회(KSC) 재무이사
  • 2013  ~  2014  :  대한심혈관합병증연구회(KCCC) 회장
  • 2014  ~  2016  :  대한심혈관중재학회(KSIC) 이사장
  • 2021  ~   :  대한심장학회 회장(차기)

국내활동

more
  • 2007  ~   :  Endovascular and Coronary Revascularization in Seoul(ENCORE SEOUL) 조직위원장

논문

more
  • [SCI] (Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice)
  • [SCI] (Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes)
  • [SCI] (Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial. TICAKOREA Investigators)
  • [SCI] (Comparison of Two-Year Outcomes of Acute Myocardial Infarction Caused by Coronary Artery Spasm Versus that Caused by Coronary Atherosclerosis)
  • [SCI] (The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes)
  • [SCI] (Association between body mass index and 1-year outcome after acute myocardial infarction)
  • [SCI] (Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry)
  • [SCI] (Radial Motor Nerve Palsy Following Transradial Coronary Intervention)
  • [SCI] (Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction - Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health)
  • [SCI] (Optimal Timing of Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure (from the Korea Acute Myocardial Infarction Registry-National Institutes of Health [KAMIR-NIH]))
  • [SCI] (Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge)
  • [SCI] (Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention - 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial)
  • [SCI] (Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease)
  • [SCI] (A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy)
  • [SCI] (Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients)
  • [SCI] (Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort)
  • [SCI] (Polymer-free sirolimus-eluting stents in a large-scale all-comers population)
  • [SCI] (Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP)
  • [SCI] (Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction)
  • [SCI] (Comparison of Outcomes after Device Closure with Transseptal Puncture and Standard Technique in Patients with Patent Foramen Ovale and Ischemic Events)
  • [SCI] (Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea))
  • [SCI] (Intravascular ultrasound-guided retrograde percutaneous coronary intervention of a chronic total occlusion)
  • [SCI] (Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial)
  • [SCI] (Trial of everolimus-eluting stents or bypass surgery for coronary disease)
  • [SCI] (Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy)
  • [SCI] (Everolimus-eluting Xience V/Promus versus Zotarolimus-eluting Resolute stent in patients with diabetes mellitus)
  • [SCI] (Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the Korean acute myocardial infarction registry and Korean myocardial infarction registry)
  • [SCI] (The role of ergonovine provocation test on active vasodilator therapy)
  • [SCI] (A comparison of two brands of clopidogrel in patients with drug-eluting stent implantation)
  • [SCI] (Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study ; IRIS-DES Investigators)
  • [SCI] (Repeated sudden cardiac death in coronary spasm: is IVUS helpful to decide treatment strategy?)
  • [SCI] (Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study)
  • [SCI] (Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial)
  • [SCI] (Long-term safety and efficacy of pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study (LAMIS))
  • [SCI] (Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial)
  • [SCI] (The Effects of Statin and Niacin on Plaque Stability, Plaque Regression, Inflammation and Oxidative Stress in Patients with Mild to Moderate Coronary Artery Stenosis)
  • [SCI] (Characteristics and predictors of drug-eluting stent thrombosis: results from the multicenter 'Korea Stent Thrombosis (KoST)' registry)
  • [SCI] (Predictors of edge stenosis after paclitaxel-eluting stent implantation)
  • [SCI] (Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry)
  • [SCI] (Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial)
  • [SCI] (Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry)
  • [SCI] (Real-Time 3-Dimensional Echocardiography of the Heart 13 Years After Partial Left Ventriculectomy)
  • [SCI] (Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators))
  • [SCI] (Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents)
  • [SCI] (Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial)
  • [SCI] (Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]))
  • [SCI] (Stents versus coronary-artery bypass grafting for left main coronary artery disease)
  • [SCI] (Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial)
  • [SCI] (Influence of stent expansion states on platelet deposition in an extracorporeal porcine arteriovenous shunt model using a multichannel perfusion channel)

저서

more
  • 심혈관중재매뉴얼
  • VIS Manuel
  • KVIS Manuel
  • 심혈관합병증 매뉴얼

최종수정일 : 2020.11.16